best use practices for clinicians prescribing interferon to patients with mpns
Published 2 months ago • 70 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
3:40
recommendations for physicians treating pv: selecting between hydroxyurea and interferon
-
1:30
advancements in prognostication tools in mpns in recent years
-
1:39
challenges associated with the use of novel gvhd therapies in clinical practice
-
3:13
sharing nursing best practice globally: from junior to expert
-
58:11
crafting the new treatment mix in cll
-
59:26
doing more with less: the advantages of optimizing blood collection volumes for laboratory testing
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
3:21
the cll patient journey: improving communication between physicians and patients
-
1:53
preclinical research for the future of cellular therapies
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
2:44
the main barriers to treatment access for patients with cll
-
4:02
treatment-free intervals: what is best for patients?
-
2:09
heart transplantation in attr amyloidosis
-
0:56
improving therapeutic approaches for patients with ph-like all & the importance of disease biology
-
2:14
trial updates for luspatercept in lr-mds: commands, medalist and elements-mds
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
1:41
developing novel gene therapy approaches for hemoglobinopathies
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment